Clinton Unveils Pact To Slash AIDS Drug Prices

Law360, New York (May 9, 2007, 12:00 AM EDT) -- While developing countries continue to break AIDS drug patents, former President Bill Clinton has negotiated a new deal with two pharmaceutical giants in an attempt to provide poor nations with cheaper versions of drugs needed to combat the deadly disease.

On Tuesday, the former president revealed that his charitable organization, the Clinton Foundation, had brokered a deal with Cipla and Matrix that will slash the price of AIDS treatment for second-line anti-retroviral drugs (ARVs).

"Seven million people in the developing world are in need of treatment...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.